https://allsci.com/news/regulatory/galleri-multi-cancer-blood-test-fda-convenes/ AllScien 2026-08-10T14:39:13.471542Z GRAIL’s Galleri becomes first multi-cancer detection test headed to US FDA advisory panel https://allsci.com/news/research/immune-cells-aging-brain-stanford-researchers/ AllScien 2026-08-10T14:33:04.134141Z Stanford researchers uncover blood-to-brain immune cell migration in human aging https://allsci.com/news/research/mrsa-dna-polymerase-structure-acurx-maps-to/ AllScien 2026-08-10T14:22:58.608118Z Acurx and Leiden University Medical Center target first inhibitor-bound MRSA PolC structure https://allsci.com/news/pharma/jazz-pharmaceuticals-actio-acquisition-acquires/ AllScien 2026-08-10T13:57:16.933654Z Jazz moves on Actio Bio for up to USD 1.3b to enter KCNT1-driven epilepsy market https://allsci.com/news/policy/biotech-investments-china-screening-slotkin-and/ AllScien 2026-08-10T12:39:37.001935Z US bill could subject China-to-US pharma licensing deals to national security controls https://allsci.com/news/funding/ve303-phase-iii-trial-funding-vedanta-secures-usd/ AllScien 2026-08-10T12:28:17.675481Z Vedanta secures USD 60m ahead of Phase III VE303 recurrent C. difficile readout https://allsci.com/news/regulatory/fda-fast-track-designation-grand-pharmas/ AllScien 2026-08-10T11:04:13.855774Z Grand Pharma's FAP-targeted imaging agent earns FDA Fast Track designation https://allsci.com/news/clinical-trials/lz901-zoster-vaccine-efficacy-luzhus-shows-916/ AllScien 2026-08-10T10:58:09.589325Z Luzhu’s LZ901 shingles vaccine Phase III results published in Nature Communications https://allsci.com/news/clinical-trials/kras-g12d-inhibitor-nsclc-gfh375-becomes-first/ AllScien 2026-08-10T10:33:20.325252Z Genfleet becomes first to test oral KRAS G12D inhibitor in Phase III for NSCLC https://allsci.com/news/regulatory/apitegromab-bla-fda-approval-scholar-rocks/ AllScien 2026-08-10T10:21:59.911628Z Scholar Rock shifts apitegromab BLA to second fill-finish site after Catalent FDA inspection https://allsci.com/news/licensing-and-partnerships/precision-oncology-biomarkers-hanchorbio-partners/ AllScien 2026-08-10T08:42:52.312673Z HanchorBio partners with Taiwan Cancer Moonshot to guide FBDB pipeline with multi-omics biomarkers https://allsci.com/news/research/ai-bacteriophages-e-coli-stanford-researchers-use/ AllScien 2026-08-10T08:39:37.581374Z Stanford researchers use Evo AI models to design novel bacteriophages against E. coli https://allsci.com/news/earnings-call-insights/beone-brukinsa-earnings-guidance-raises-full-year/ AllScien 2026-08-10T07:08:53.860167Z BeOne Q2'26: RAS-ON ADC unveiled as five solid tumor programs race toward Phase III